Rani Therapeutics Holdings, Inc. (RANI) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts RANI Hot Sheet
Join SI Premium – FREE
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q3 EPS of ($0.12), $0.05 better than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hyperscale Data chairman plans open-market stock purchases
- Five Below (FIVE) Tops Q2 EPS by 35c, Beats on Revenue; Offers Q3 Revenue Guidance
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
